Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor internal update or maintenance version rather than a change to displayed content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a generic error message stating the page is unavailable. This replaces the previously visible study record content and its documents.SummaryDifference20%

- Check41 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a new release/version of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating an updated document version.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer build of the page.SummaryDifference0.0%

- Check84 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the page revision label updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.